Diana Resetca

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The N-Myc MB0-MBI region interacts specifically and dynamically with the N-lobe of Aurora kinase A.

The N-Myc MB0-MBI region interacts specifically and dynamically with the N-lobe of Aurora kinase A.

Journal: Nature communications

Published: March 20, 2025

Identifying and Validating MYC:Protein Interactors in Pursuit of Novel Anti-MYC Therapies.

Identifying and Validating MYC:Protein Interactors in Pursuit of Novel Anti-MYC Therapies.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 21, 2021

MYC protein interactors in gene transcription and cancer.

MYC protein interactors in gene transcription and cancer.

Journal: Nature reviews. Cancer

Published: May 04, 2021

11th Tuscany Retreat on Cancer Research and Apoptosis: Genetic profiling, resistance mechanisms and novel treatment concepts in cancer and neurodegeneration.

11th Tuscany Retreat on Cancer Research and Apoptosis: Genetic profiling, resistance mechanisms and novel treatment concepts in cancer and neurodegeneration.

Journal: Cell death & disease

Published: November 16, 2019

Multiple direct interactions of TBP with the MYC oncoprotein.

Multiple direct interactions of TBP with the MYC oncoprotein.

Journal: Nature structural & molecular biology

Published: April 11, 2019

MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.

MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.

Journal: Molecular cell

Published: April 11, 2018

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.

Journal: Leukemia

Published: May 04, 2017

MYC Deregulation in Primary Human Cancers.

MYC Deregulation in Primary Human Cancers.

Journal: Genes

Published: March 23, 2017

MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability.

MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability.

Journal: Nature communications

Published: November 23, 2016

Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns.

Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: August 05, 2016

Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent.

Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent.

Journal: Oncotarget

Published: October 15, 2015

Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization.

Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization.

Journal: The Journal of biological chemistry

Published: October 08, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026